Institution: | 1. Department of Geriatrics, The Second Xiangya Hospital of Central South University, Middle Renmin Rd., Furong District, Changsha, Hunan, 410011, China;2. Yale School of Nursing, Yale University West Campus, Building 400, 300 Heffernan Drive, West Haven, CT 06516, USA;3. Cardiology Department, The Third Xiangya Hospital of Central South University, Western Tongzipo Rd, Yuelu District, Changsha, Hunan, 410013, China |
Abstract: | BackgroundMultidisciplinary disease management programs (MDMP) for patients with heart failure (HF) have been delivered, but evidence of their effectiveness in China is limited.ObjectiveTo determine if a MDMP improves quality of life (QoL), physical performance, depressive symptoms, self-care behaviors and mortality or rehospitalization in patients with HF in China.MethodsThis is a randomized controlled single center trial in which patients with HF received either MDMP with discharge education, physical training, follow-up visits and telephone calls for 180 days (n = 31) or standard care (SC, n = 31).ResultsCompared with SC, QoL, depressive symptoms, and self-care behaviors were significantly improved by MDMP from baseline to 180 days (37% vs 66%, 20% vs 61%, and 8% vs 33%, respectively, all p < 0.001). There were no differences in physical performance and mortality or rehospitalization during follow-up.ConclusionsA HF MDMP can improve QoL, depressive symptoms and self-care behaviors in China. |